| Medical and Health Sciences | Lifetime | 230 | US 125 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 18 | US 10 | 99.99 |
| Cardiology and Cardiovascular Medicine | Lifetime | 95 | US 52 | 99.91 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 91 | US 51 | 99.71 |
| Medical Physiology | Lifetime | 188 | US 108 | 99.71 |
| Hematology | Lifetime | 199 | US 105 | 98.89 |
| Complementary and Alternative Medicine | Lifetime | 436 | US 154 | 97.43 |
| Nephrology | Lifetime | 615 | US 292 | 92.66 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 9 | US 6 | 99.95 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 22 | US 14 | 99.91 |
| Hematology | 2021-2025 | 109 | US 56 | 97.61 |
| Medical Physiology | 2021-2025 | 431 | US 159 | 93.94 |
| Epidemiology | 2021-2025 | 809 | US 289 | 92.01 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 730 | US 265 | 90.78 |
| Erythropoietin and Anemia Treatment | Lifetime | 3 | US 2 | 99.85 |
| Heart Failure Treatment and Management | Lifetime | 11 | US 7 | 99.94 |
| Nutrition and Health in Aging | Lifetime | 10 | US 7 | 99.93 |
| Cardiovascular Function and Risk Factors | Lifetime | 38 | US 28 | 99.92 |
| GDF15 and Related Biomarkers | Lifetime | 2 | US 1 | 99.60 |
| Iron Metabolism and Disorders | Lifetime | 17 | US 10 | 99.67 |
| Diabetes Treatment and Management | Lifetime | 30 | US 17 | 99.83 |
| Cardiac Fibrosis and Remodeling | Lifetime | 18 | US 12 | 99.52 |
| Body Composition Measurement Techniques | Lifetime | 45 | US 20 | 99.36 |
| Cardiac pacing and defibrillation studies | Lifetime | 147 | US 81 | 99.45 |
| Pancreatic function and diabetes | Lifetime | 298 | US 137 | 99.02 |
| Potassium and Related Disorders | Lifetime | 49 | US 31 | 98.84 |
| Muscle Physiology and Disorders | Lifetime | 234 | US 110 | 98.48 |
| Cardiovascular and exercise physiology | Lifetime | 330 | US 130 | 98.49 |
| Hemoglobinopathies and Related Disorders | Lifetime | 647 | US 329 | 97.00 |
| Signaling Pathways in Disease | Lifetime | 317 | US 164 | 96.61 |
| Cardiac Structural Anomalies and Repair | Lifetime | 968 | US 542 | 97.49 |
| Frailty in Older Adults | Lifetime | 582 | US 208 | 96.20 |
| Dialysis and Renal Disease Management | Lifetime | 1,000 | US 364 | 95.96 |
| Electrolyte and hormonal disorders | Lifetime | 863 | US 406 | 93.88 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 508 | US 233 | 91.72 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 515 | US 155 | 91.69 |
| Vitamin C and Antioxidants Research | Lifetime | 720 | US 295 | 92.00 |
| Heart rate and cardiovascular health | Lifetime | 172 | US 53 | 89.26 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 1 | US 1 | 99.79 |
| Iron Metabolism and Disorders | 2021-2025 | 3 | US 2 | 99.56 |
| Pancreatic function and diabetes | 2021-2025 | 6 | US 4 | 99.81 |
| Diabetes Treatment and Management | 2021-2025 | 10 | US 7 | 99.92 |
| Heart Failure Treatment and Management | 2021-2025 | 8 | US 5 | 99.91 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 22 | US 12 | 99.87 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 101 | US 43 | 98.65 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 103 | US 37 | 96.41 |
| Potassium and Related Disorders | 2021-2025 | 31 | US 15 | 97.32 |
| Hormonal Regulation and Hypertension | 2021-2025 | 110 | US 31 | 95.74 |
| Nutrition and Health in Aging | 2021-2025 | 385 | US 62 | 95.65 |
| Cardiac Valve Diseases and Treatments | 2021-2025 | 856 | US 304 | 94.85 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 819 | US 361 | 91.82 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 821 | US 268 | 89.44 |
| GDF15 and Related Biomarkers | 2021-2025 | 88 | US 22 | 84.34 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 676 | US 309 | 88.08 |
| Electrolyte and hormonal disorders | 2021-2025 | 190 | US 60 | 85.26 |
| Adrenal Hormones and Disorders | 2021-2025 | 490 | US 70 | 75.99 |
| Renal function and acid-base balance | 2021-2025 | 448 | US 137 | 65.09 |
| Cardiovascular and Diving-Related Complications | 2021-2025 | 691 | US 140 | 63.24 |
| Heart rate and cardiovascular health | 2021-2025 | 141 | US 32 | 53.41 |